HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R E Widdop Selected Research

Hyperplasia

10/2014A novel agent with histone deacetylase inhibitory activity attenuates neointimal hyperplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R E Widdop Research Topics

Disease

1Pathologic Constriction (Stenosis)
10/2014
1Hyperplasia
10/2014
1Cardiovascular Diseases (Cardiovascular Disease)
02/2010
1Gliosis
01/2004
1Retrograde Degeneration
01/2004
1Hypertrophy
08/2001
1Cardiomegaly (Heart Hypertrophy)
08/2001

Drug/Important Bio-Agent (IBA)

2Angiotensin IIIBA
01/2004 - 08/2001
1Histone Deacetylases (Histone Deacetylase)IBA
10/2014
1compound 21IBA
02/2010
1PK 11195 (PK11195)IBA
01/2004
1CGP 42112AIBA
01/2004
1Glial Fibrillary Acidic ProteinIBA
01/2004
1Hydralazine (Apresoline)FDA LinkGeneric
08/2001
1Angiotensin IIBA
08/2001
1candesartan cilexetil (Amias)FDA Link
08/2001
1PerindoprilFDA LinkGeneric
08/2001
1Antihypertensive Agents (Antihypertensives)IBA
08/2001

Therapy/Procedure

1Stents
10/2014
1Ganglionectomy
01/2004